Andy Burnhams Manchester Vision A Model for Regional Economic Policy and Investment Potential White House Announces Soybean and Rare Earths Deals After TrumpXi Summit China Highlights Tariff Reductions Trump Signals Potential Decision on Iran Nuclear Deal by Sunday Geopolitical Tensions Could Impact Oil Markets US Stock Markets Advance as Tech Gains and USIran Talks Boost Investor Sentiment Young Workers in Spain Face Rent Burden of Nearly 987 of Wages as Emancipation Rate Hits Record Low IBR vs RAP Choosing the Right Federal Student Loan Repayment Plan BH Q1 2025 Earnings EPS of 2337 Reported Amid Limited Disclosure EQR Q1 2026 Earnings EPS Falls Short of Estimates by 257 SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Navigates Pipeline Costs Emerson Radio MSN Q1 2024 Earnings Loss of 003 per Share Triggers 20 Stock Surge Climb Bio Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment CON Q1 2026 Earnings Solid EPS Beat Masks Cautious Market Sentiment Barrick Mining B Surges 265 Bullish Momentum Testing Key Resistance Levels SR Bancorp SRBK Holds Steady Near Support Amid Low Volume H2O America HTO Slips 093 as Shares Test MidRange Support TTM Technologies TTMI Faces Sharp Decline Amid Sector Headwinds Key Support Levels in Focus Quince Therapeutics QNCX Edges Higher Navigating Key Levels Near Resistance BWXT Q1 2026 Earnings Strong EPS Beat Driven by Operational Excellence Eagle Point Credit Company Inc ECC Q4 2025 Earnings EPS Surpasses Estimates Stock Gains 21 DEA Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines COCP Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline Gemini Space Station Inc GEMI Q1 2026 Earnings Narrowed Loss Beats Estimates Despite Revenue Void UiPath Q1 2026 Earnings EPS Beat Drives Positive Sentiment Despite Revenue Ambiguity Bank of America Initiates Coverage on Oklo with Buy Rating Citing Early Leadership in Advanced Nuclear Energy Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights Pipeline Progress Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range